RAPP R&D Expenses

Rapport Therapeutics Inc · R&D Expenses

RAPP logo

RAPP R&D Expenses

Latest reported$136.67M
RAPP TTM R&D Expenses ($28.00M → $136.67M)
High-resolution chart · PNG

RAPP r&d expenses history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Rapport Therapeutics Inc R&D Expenses — Trailing twelve months (TTM) (USD)
Period endingR&D Expenses (USD)
136,667,000
107,933,000
94,789,000
81,730,000
74,994,000
68,003,000
60,935,000
55,535,000
47,572,000
36,604,000
27,999,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.